Beyond Air® Preannounces Preliminary Revenue for the Quarter Ended September 30, 2026
Globe Newswire•08/10/2026•08:00 ET
0
Key Highlights
- ➤Preliminary Q3 revenue $2.3 million, highest quarterly revenue reported
- ➤Q3 revenue grew approximately 30% sequentially and 27% year over year
- ➤Beyond Air reaffirmed CY2026 revenue guidance of $8 million
- ➤CY2027 revenue guidance reaffirmed at $16 million-$18 million, pending FDA approval
- ➤Second-generation LungFit PH remains under FDA review
Expert Statements
Robert Goodman, Chief Executive Officer of Beyond Air
“Our strong revenue growth in the quarter ended September 30, 2026 reflects continued adoption of LungFit PH and the value hospitals see in our cylinder-free nitric oxide technology.”
Robert Goodman, Chief Executive Officer of Beyond Air
“Over the years, we have refined our first-generation system through a series of enhancements and improvements for ease of use.”
Robert Goodman, Chief Executive Officer of Beyond Air
“The first-generation LungFit PH has established a strong track record of reliable nitric oxide delivery and has become a trusted system among our hospital customers.”
Robert Goodman, Chief Executive Officer of Beyond Air
“Our second-generation system remains under review by the FDA, and we expect demand for the LungFit PH platform to increase significantly following FDA approval.”
Robert Goodman, Chief Executive Officer of Beyond Air
“We continue to be pleased with the progress we are seeing with the ongoing PMA supplement process.”
Robert Goodman, Chief Executive Officer of Beyond Air
“Adding transport capability will qualify Beyond Air as a single source nitric oxide provider, which is the current standard across most U.S. hospital systems.”
Preliminary revenue of $2.3 million represents the highest quarterly revenue reported, and approximately 30% sequential quarterly growth and 27% growth over the same period last year
Performance reflects continued adoption for first-generation LungFit PH; second-generation system remains under FDA review
Get started
Create a free account to read the full story.